Evidence map›Paper›PMID 26860368›Full record

ArticleImmunology and cell biology2016

Fine-tuning of CD8(+) T-cell effector functions by targeting the 2B4-CD48 interaction.

Anna Lissina, David R Ambrozak, Kristin L Boswell, Wenjing Yang, Eli Boritz, Yoshiyuki Wakabayashi, Maria C Iglesias, Masao Hashimoto, Masafumi Takiguchi, Elias Haddad and 5 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Immunology and cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. WGCNA and molecular docking identify hub genes for cardiac aging.Frontiers in cardiovascular medicine · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Anna LissinaSorbonne Universités, UPMC Univ Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
David R AmbrozakImmunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Kristin L BoswellImmunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Wenjing YangSystems Biology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA.
Eli BoritzHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
Yoshiyuki WakabayashiSystems Biology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA.
Maria C IglesiasSorbonne Universités, UPMC Univ Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
Masao HashimotoCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Masafumi TakiguchiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Elias HaddadVaccine and Gene Therapy Institute of Florida, Lucie, FL, USA.
Daniel C DouekHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
Jun ZhuSystems Biology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA.ORCID 0000-0003-4573-8933
Richard A KoupImmunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Takuya YamamotoImmunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Victor AppaySorbonne Universités, UPMC Univ Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
National Institutes of Health · USInserm · FRNational Heart Lung and Blood Institute · USKumamoto University · JPNational Human Genome Research Institute · USVaccine & Gene Therapy Institute of Florida · US

Funding

DNA Sequencing Core (DSC)ZICHL006058 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ZHU, JUN · 2010 to 2016
$16.6M
RNA systems biologyZIAHL006230 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ZHU, JUN · 2017 to 2018
$1.0M
6 · The paper itself

Abstract

Polyfunctionality and cytotoxic activity dictate CD8(+) T-cell efficacy in the eradication of infected and malignant cells. The induction of these effector functions depends on the specific interaction between the T-cell receptor (TCR) and its cognate peptide-MHC class I complex, in addition to signals provided by co-stimulatory or co-inhibitory receptors, which can further regulate these functions. Among these receptors, the role of 2B4 is contested, as it has been described as either co-stimulatory or co-inhibitory in modulating T-cell functions. We therefore combined functional, transcriptional and epigenetic approaches to further characterize the impact of disrupting the interaction of 2B4 with its ligand CD48, on the activity of human effector CD8(+) T-cell clones. In this setting, we show that the 2B4-CD48 axis is involved in the fine-tuning of CD8(+) T-cell effector function upon antigenic stimulation. Blocking this interaction resulted in reduced CD8(+) T-cell clone-mediated cytolytic activity, together with a subtle drop in the expression of genes involved in effector function regulation. Our results also imply a variable contribution of the 2B4-CD48 interaction to the modulation of CD8(+) T-cell functional properties, potentially linked to intrinsic levels of T-bet expression and TCR avidity. The present study thus provides further insights into the role of the 2B4-CD48 interaction in the fine regulation of CD8(+) T-cell effector function upon antigenic stimulation.

Indexed as

Antibody AffinityCD48 AntigenCD8-Positive T-LymphocytesCytotoxicity, ImmunologicEpigenesis, GeneticHumansImmunomodulationProtein BindingReceptors, Antigen, T-CellSignaling Lymphocytic Activation Molecule FamilySignal TransductionT-bet Transcription FactorT-Box Domain ProteinsTranscription, GeneticCD244 protein, humanCD48 AntigenReceptors, Antigen, T-CellSignaling Lymphocytic Activation Molecule FamilyT-bet Transcription FactorT-Box Domain Proteins

Identifiers

PMID26860368
OpenAlexW2318566899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.